Clinical Impacts of Heterogeneous Interferon Responses to Viral Infection by Asthmatic Airway Epithelium

异质干扰素对哮喘气道上皮病毒感染反应的临床影响

基本信息

  • 批准号:
    10265757
  • 负责人:
  • 金额:
    $ 6.72万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-01 至 2022-01-31
  • 项目状态:
    已结题

项目摘要

Project Summary Asthma exacerbations among U.S children result in 640,000 emergency department visits and 14 million missed school days annually. Viral infections trigger the majority of exacerbations in children, of which human rhinoviruses (HRV) are the most common. The airway epithelium plays central roles in regulating inflammation, airway remodeling responses, and innate immune responses to infection. The most striking response of airway epithelial cells (AECs) to viral infection is expression of type I and III interferons (IFN I/III) and IFN stimulated genes (ISG). Some have reported deficient IFN I/III responses to viral infection by asthmatic AECs and postulated that deficient epithelial IFN responses to viruses predispose to exacerbations, whereas others have not observed differences in AEC IFN responses to viruses between asthmatic and healthy AECs. In our unique cohort of well characterized asthmatic and healthy children, from whom we obtain bronchial and nasal AECs and conduct mechanistic experiments using air-liquid-interface organotypic culture models, we have observed significant heterogeneity in IFN I/III responses to HRV and RSV infection. For example, among our asthmatic AEC donors we have noted associations between high type I/III IFN responses and lower donor lung function, as well as distinct subgroups of exacerbation prone asthmatics with deficient IFN I/III responses to HRV. Heterogeneity in AEC IFN I/III responses to viral infections may be explained by polymorphisms in genes coding for viral sensors and/or key steps in signal transduction pathways upstream of IFN I and III. The overall goal my research program is to understand how airway epithelial responses influence viral-triggered exacerbations and airway remodeling mechanisms in asthmatic children. In the first aim, using primary cells from children with asthma we will test our hypothesis that polymorphisms in genes coding for viral sensors, and/or key steps in signal transduction pathways upstream of IFN responses, contribute to heterogeneity in IFN I/III responses to HRV infection by AECs from asthmatic children. In the second aim, we will prospectively follow a cohort of asthmatic children to test our hypothesis that deficient AEC IFN I/III responses to HRV are associated with a greater incidence of viral-triggered exacerbations in AEC donors. In the final aim, we will test our hypothesis that excessively high IFN I/III responses by asthmatic AECs to HRV are associated with lung function decline among AEC donors, and we will interrogate potential mechanisms whereby excessively high IFN I/III responses may promote proliferation and activation of lung stromal cells. The studies conducted in my research program and unique resource of primary airway epithelial cells from clinically well characterized asthmatic children provide an exceptional training environment for young investigators dedicated to a career in mechanistic patient-oriented research to learn translational research techniques to investigate the role of the airway epithelium in pediatric lung diseases and viral infection.
项目摘要 美国儿童哮喘恶化导致640,000次急诊和1400万次 每年都错过上学的日子。病毒感染引发大多数儿童病情加重,其中人类 鼻病毒(HRV)是最常见的。气道上皮细胞在调节 炎症、气道重塑反应和对感染的先天免疫反应。最引人注目的 呼吸道上皮细胞(AEC)对病毒感染的反应是表达I型和III型干扰素(IFN I/III) 和IFN刺激基因(ISG)。一些人报道了IFN I/III对病毒感染的应答缺陷, 哮喘的AEC,并假设上皮细胞对病毒的IFN应答缺陷易使病情加重, 而其他人没有观察到哮喘和哮喘患者之间AEC IFN对病毒的反应存在差异, 健康的AEC。在我们独特的哮喘儿童和健康儿童队列中,我们从他们那里获得了 支气管和鼻AEC,并使用气液界面器官型培养进行机械实验 模型,我们已经观察到显着的异质性IFN I/III响应HRV和RSV感染。为 例如,在我们的哮喘AEC供体中,我们注意到I/III型IFN高应答与 和较低的供体肺功能,以及不同的亚组的急性发作倾向的哮喘患者, IFN I/III对HRV的反应。AEC IFN I/III对病毒感染的应答中的异源性可解释为: 编码病毒传感器的基因的多态性和/或信号转导途径上游的关键步骤, IFN I和IFN III。我的研究项目的总体目标是了解气道上皮细胞如何 影响哮喘儿童病毒触发的急性发作和气道重塑机制。在 第一个目标是,使用来自哮喘儿童的原代细胞,我们将检验我们的假设, 编码病毒传感器的基因,和/或IFN应答上游信号转导途径中的关键步骤, 哮喘患儿AEC对HRV感染的IFN I/III反应的异质性。在 第二个目的,我们将前瞻性地跟踪一组哮喘儿童,以验证我们的假设,即缺乏 AEC对HRV的IFN I/III应答与病毒触发的AEC急性加重的发生率较高相关 捐助者。在最后的目标,我们将测试我们的假设,过高的IFN I/III反应的哮喘, AEC对HRV的影响与AEC供体的肺功能下降有关,我们将询问潜在的 过高的IFN I/III应答可能促进肺增殖和活化的机制 基质细胞在我的研究项目中进行的研究和原发性气道上皮细胞的独特资源 来自临床上表现良好的哮喘儿童的细胞为年轻人提供了一个特殊的训练环境, 研究人员致力于以患者为导向的机械研究的职业生涯,以学习转化研究 研究呼吸道上皮细胞在小儿肺部疾病和病毒感染中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JASON S DEBLEY其他文献

JASON S DEBLEY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JASON S DEBLEY', 18)}}的其他基金

Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling
哮喘上皮干扰素对病毒的反应失调会导致病情加重、T2 炎症和气道重塑
  • 批准号:
    10558633
  • 财政年份:
    2022
  • 资助金额:
    $ 6.72万
  • 项目类别:
Dysregulated asthmatic epithelial interferon responses to viruses drive exacerbation, T2 inflammation, and airway remodeling
哮喘上皮干扰素对病毒的反应失调会导致病情加重、T2 炎症和气道重塑
  • 批准号:
    10446799
  • 财政年份:
    2022
  • 资助金额:
    $ 6.72万
  • 项目类别:
Clinical Impacts of Heterogeneous Interferon Responses to Viral Infection by Asthmatic Airway Epithelium
异质干扰素对哮喘气道上皮病毒感染反应的临床影响
  • 批准号:
    10552683
  • 财政年份:
    2020
  • 资助金额:
    $ 6.72万
  • 项目类别:
Clinical Impacts of Heterogeneous Interferon Responses to Viral Infection by Asthmatic Airway Epithelium
异质干扰素对哮喘气道上皮病毒感染反应的临床影响
  • 批准号:
    10330561
  • 财政年份:
    2020
  • 资助金额:
    $ 6.72万
  • 项目类别:
Dysregulated Airway Epithelial Signaling as a Driver of Airway Remodeling in Asthmatic Children
气道上皮信号失调是哮喘儿童气道重塑的驱动因素
  • 批准号:
    9130413
  • 财政年份:
    2015
  • 资助金额:
    $ 6.72万
  • 项目类别:
NONINVASIVE MEASURES OF AIRWAY INFLAMMAITON AND AIRFLOW OBSTRUCTION IN WHEEZY
喘息时气道炎症和气流阻塞的非侵入性治疗
  • 批准号:
    7603558
  • 财政年份:
    2007
  • 资助金额:
    $ 6.72万
  • 项目类别:
AIRFLOW OBSTRUCTION AND BIOMARKERS OF AIRWAY DURING AND FOLLOWING OF ASTHMA
哮喘期间和之后的气流阻塞和气道生物标志物
  • 批准号:
    7603551
  • 财政年份:
    2007
  • 资助金额:
    $ 6.72万
  • 项目类别:
AIRFLOW OBSTRUCTION AND BIOMARKERS OF AIRWAY INFLAMATION
气流阻塞和气道炎症的生物标志物
  • 批准号:
    7379438
  • 财政年份:
    2006
  • 资助金额:
    $ 6.72万
  • 项目类别:
Noninvasive Measures in Wheezy Infants and Toddlers
喘息婴幼儿的无创治疗
  • 批准号:
    6956540
  • 财政年份:
    2005
  • 资助金额:
    $ 6.72万
  • 项目类别:
Noninvasive Measures in Wheezy Infants and Toddlers
喘息婴幼儿的无创治疗
  • 批准号:
    7103668
  • 财政年份:
    2005
  • 资助金额:
    $ 6.72万
  • 项目类别:

相似国自然基金

湍流和化学交互作用对H2-Air-H2O微混燃烧中NO生成的影响研究
  • 批准号:
    51976048
  • 批准年份:
    2019
  • 资助金额:
    61.0 万元
  • 项目类别:
    面上项目

相似海外基金

Air pollution and Asthma in Canada: Projections of burden and the value of climate adaptation strategies
加拿大的空气污染和哮喘:负担预测和气候适应战略的价值
  • 批准号:
    485322
  • 财政年份:
    2023
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Operating Grants
Urban planning, siting of air pollution sources, and asthma disparities
城市规划、空气污染源选址和哮喘差异
  • 批准号:
    10567693
  • 财政年份:
    2023
  • 资助金额:
    $ 6.72万
  • 项目类别:
Evaluation of radon progeny and air pollution effects in asthma
评估氡子体和空气污染对哮喘的影响
  • 批准号:
    10723709
  • 财政年份:
    2023
  • 资助金额:
    $ 6.72万
  • 项目类别:
Action towards health equity and improved air quality in the Duwamish Valley: A multilevel asthma intervention
杜瓦米什山谷的健康公平和空气质量改善行动:多层次哮喘干预
  • 批准号:
    10562132
  • 财政年份:
    2023
  • 资助金额:
    $ 6.72万
  • 项目类别:
Investigating the interactions of air pollution and an anti-inflammatory asthma medication using scRNA sequencing
使用 scRNA 测序研究空气污染和抗炎哮喘药物的相互作用
  • 批准号:
    485433
  • 财政年份:
    2023
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Salary Programs
Molecular Mechanisms for Resolving Air Pollution Induced Pulmonary Inflammation: Potential Differences by Asthma and Sex (RAPIDAS)
解决空气污染引起的肺部炎症的分子机制:哮喘和性别的潜在差异(RAPIDAS)
  • 批准号:
    10718525
  • 财政年份:
    2023
  • 资助金额:
    $ 6.72万
  • 项目类别:
There's something in the air: disentangling the role of airborne microbes and pollutants in the inflammatory response of asthma along a latitudinal gradient in Canada
空气中弥漫着某种东西:沿着加拿大的纬度梯度,理清空气中的微生物和污染物在哮喘炎症反应中的作用
  • 批准号:
    571457-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 6.72万
  • 项目类别:
    Alliance Grants
Puerto Rico Asthma Integrated Response Program (PR-AIR)
波多黎各哮喘综合应对计划 (PR-AIR)
  • 批准号:
    10705253
  • 财政年份:
    2022
  • 资助金额:
    $ 6.72万
  • 项目类别:
Puerto Rico Asthma Integrated Response Program (PR-AIR)
波多黎各哮喘综合应对计划 (PR-AIR)
  • 批准号:
    10534086
  • 财政年份:
    2022
  • 资助金额:
    $ 6.72万
  • 项目类别:
Contextualizing Asthma Self-Management with Measures of Indoor Air Quality for Black Adults with Uncontrolled Asthma
将哮喘自我管理与哮喘不受控制的黑人成人的室内空气质量测量结合起来
  • 批准号:
    10671775
  • 财政年份:
    2022
  • 资助金额:
    $ 6.72万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了